Related Experiment Video
Updated: Apr 6, 2026

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity
Kuo Du1, Yuchao Xie1, Mitchell R McGill1
1a University of Kansas Medical Center, Department of Pharmacology, Toxicology and Therapeutics , Kansas City, KS, USA +1 913 588 7969 ; +1 913 588 7501 ; hjaeschke@kumc.edu.
Background:
Acetaminophen (APAP) overdose is the leading cause of acute liver failure in the US. Although substantial progress regarding the mechanisms of APAP hepatotoxicity has been made in the past several decades, therapeutic options are still limited and novel treatments are clearly needed. c-jun N-terminal Kinase (JNK) has emerged as a promising therapeutic target in recent years.
Areas Covered:
Early studies established the critical role of JNK activation and mitochondrial translocation in APAP hepatotoxicity. However, this concept has also been challenged. Initial studies failed to reproduce the protection of JNK deficiency in APAP toxicity and concerns over off-target effects of JNK inhibitors and even in knock-out mice are increasing. Interestingly, recent studies have even shown that liver injury can be altered with or without effects on JNK activation. The current review addresses these discrepancies and tries to explain or reconcile some of the conflicting results.
Expert Opinion:
JNK is a potential therapeutic target for APAP poisoning. However, controversies still exist regarding its actual role in APAP hepatotoxicity. Future studies are warranted for more in-depth testing of specific inhibitors in well-defined preclinical models and human hepatocytes before JNK can be considered a relevant therapeutic target for APAP poisoning.
Insights
Acetaminophen (APAP) overdose causes liver failure. While c-jun N-terminal Kinase (JNK) is a potential target, its role in APAP liver injury remains controversial, requiring further research.
Area of Science:
- Hepatology
- Toxicology
- Molecular Biology
Background:
- Acetaminophen (APAP) overdose is a primary cause of acute liver failure in the U.S.
- Current therapeutic options for APAP-induced liver injury are limited, necessitating novel treatment strategies.
- c-jun N-terminal Kinase (JNK) signaling pathways have been identified as a potential therapeutic target.
Purpose of the Study:
- To review and reconcile conflicting findings regarding the role of JNK activation in APAP hepatotoxicity.
- To critically evaluate the therapeutic potential of targeting JNK for APAP poisoning.
Main Methods:
- Review of early and recent studies on JNK activation in APAP hepatotoxicity.
- Analysis of discrepancies in findings related to JNK deficiency and inhibitor effects.
- Examination of recent studies showing variable effects on liver injury independent of JNK activation.
Main Results:
- Early studies suggested a critical role for JNK activation and mitochondrial translocation in APAP hepatotoxicity.
- Subsequent studies failed to consistently reproduce the protective effects of JNK deficiency.
- Recent research indicates that liver injury can be modulated with or without significant changes in JNK activation.
Conclusions:
- JNK remains a potential therapeutic target for APAP poisoning.
- Significant controversies persist regarding the precise role of JNK in APAP-induced liver injury.
- Further investigation with specific inhibitors in preclinical models and human hepatocytes is essential to validate JNK as a therapeutic target.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Toxicity: Dose-Dependent Reactions
Bioactivation and Tissue Toxicity
Acute Kidney Injury II: Pathophysiology

